Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.93 and traded as high as $2.95. Mesoblast shares last traded at $2.20, with a volume of 6,144 shares trading hands.
Mesoblast Stock Up 19.6 %
The stock’s fifty day simple moving average is $1.28 and its 200 day simple moving average is $0.93.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Read More
- Five stocks we like better than Mesoblast
- Why Are These Companies Considered Blue Chips?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Using the MarketBeat Stock Split Calculator
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Differences Between Momentum Investing and Long Term Investing
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
